Press Releases

Citing concerns over a payment formula that creates imbalance and threatens patient access to pathology services, the CAP opposes the out-of-network reimbursement provisions included in the Lower Health Care Costs Act.

The Foundation for the Accreditation of Cellular Therapy (FACT) has approved the College of American Pathologists (CAP) as an accrediting organization for laboratories providing histocompatibility services for cellular therapy transplant patients. The CAP will be accepted in FACT Accreditation applications and included in FACT Standards because of the approval.

The CAP issued a statement following the release of a legislative outline by Rep. Raul Ruiz, MD, to tackle surprise out-of-network medical bills by developing a fair reimbursement system for patient care and alternative dispute resolution process.

The CAP releases its 2018 Annual Report.

The CAP supports congressional action to protect patients from receiving surprise out-of-network bills, which often lead to financial and emotional stress. The CAP calls on Congress to pass commonsense legislation to address the issue of surprise bills that protects patients from financial risk of out-of-network bills, ensures the financial viability of the health care delivery system, and preserves patient access to physician specialists. The CAP looks forward to supporting legislation that includes these core provisions.

The CAP commended officials in the state of Washington for enacting law to protect patients from surprise out-of-network medical bills by banning balance billing for certain out-of-network services and requiring health insurance plans to maintain adequate networks of physicians at in-network hospitals and facilities. Washington Gov. Jay Inslee signed the bill into law on May 21. State law now requires regulators to determine whether the insurance carrier’s provider network has a sufficient number of contracted physicians, including emergency, surgical, and other specialty physicians such as pathologists.

Update to CAP-ASCO guideline for endocrine testing in breast cancer open for public comment.

The CAP, along with laboratory industry groups, requested a meeting with the Government Accountability Office (GAO) to discuss strong disagreements with a recent GAO report concerning new Medicare payment rates for clinical laboratory services as mandated by the Protecting Access to Medicare Act (PAMA).

CAP announces evidence-based guideline on monoclonal gammopathy diagnosis is open for public comment.

Evidence-based guideline supports HER2 quantitative image analysis for breast cancer